Close Menu

NEW YORK – Infectious disease diagnostic firm Karius has raised $165 million in a Series B financing round led by SoftBank Vision Fund 2.

The Redwood City, California-based firm will use the funding to expand access to its microbial cell-free DNA technology to help doctors diagnose infectious diseases. Karius will also use the money to broaden clinical development and accelerate technology innovation.

The funding round also included new investors General Catalyst and HBM Healthcare Investments, as well as existing ventures Khosla Ventures and Lightspeed Venture Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.